| Autor: |
Su, Kexin, Shi, Lu, Sheng, Tao, Yan, Xinxin, Lin, Lixin, Meng, Chaoyang, Wu, Shiqi, Chen, Yuxuan, Zhang, Yao, Wang, Chaorong, Wang, Zichuan, Qiu, Junjie, Zhao, Jiahui, Xu, Tengfei, Ping, Yuan, Gu, Zhen, Liu, Shuai |
| Předmět: |
|
| Zdroj: |
Nature Communications; 7/5/2024, Vol. 15 Issue 1, p1-12, 12p |
| Abstrakt: |
Fully targeted mRNA therapeutics necessitate simultaneous organ-specific accumulation and effective translation. Despite some progress, delivery systems are still unable to fully achieve this. Here, we reformulate lipid nanoparticles (LNPs) through adjustments in lipid material structures and compositions to systematically achieve the pulmonary and hepatic (respectively) targeted mRNA distribution and expression. A combinatorial library of degradable-core based ionizable cationic lipids is designed, following by optimisation of LNP compositions. Contrary to current LNP paradigms, our findings demonstrate that cholesterol and phospholipid are dispensable for LNP functionality. Specifically, cholesterol-removal addresses the persistent challenge of preventing nanoparticle accumulation in hepatic tissues. By modulating and simplifying intrinsic LNP components, concurrent mRNA accumulation and translation is achieved in the lung and liver, respectively. This targeting strategy is applicable to existing LNP systems with potential to expand the progress of precise mRNA therapy for diverse diseases. Targeted delivery of mRNA using lipid nanoparticles is currently a challenge. Here, the authors examine the composition of LNPs and report changes to the standard formulation can address issues with liver accumulation and allow for increased tissue specific targeting. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink